Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Viekirax and Exviera for the Treatment of Chronic Hepatitis C Virus Infection

Drug (Brand / Generic)

Viekirax / Ombitasvir/Paritaprevir/Ritonavir + Exviera / Dasabuvir

Company / Licensee

Abbvie / Enanta Pharmaceuticals

Current Indication

Chronic hepatitis C genotype 1 infection and compensated cirrhosis

Market Sector

Anti-infectives

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top